University of Oklahoma
*Sr. Staff Research Assistant (Project Management)
Research Focus: The focus of our research program is to better understand how inflammation increases the risk of abnormal blood vessel development in prematurely born infants and ultimately find ways to prevent complications related to vascular dysgenesis. Retinopathy of prematurity (ROP) can lead to varying degrees of lifelong visual impairment and blindness in preterm infants. Our primary objective is to leverage basic, translational, and clinical research approaches to address and mitigate the vascular developmental abnormalities observed in retinal disease, premature lung conditions, and hemorrhagic or ischemic brain disorders. The Developmental Vascular Biology Group is housed in a state-of-the-art 860 sq foot laboratory supported by OUHSC central imaging, histology, genomics and data science cores. We actively participate in clinical trials involving therapeutics and clinical aspects of ROP in the neonatal subjects at the OUHSC Children's Hospital of Oklahoma. To date, our program has secured over $5.5 Million in research funding from various sources, including the National Institute of Health/National Eye Institute, industry partners, and private foundations.
We discovered that the immunomodulatory surfactant protein a (SP-A) is expressed in the retina and defined the pro-angiogenic neovascular phenotype of SP-A in a mouse ROP model as well as in preterm infants, but the molecular mechanisms are not currently known. We utilize a multi-pronged approach to interrogate vascular and endothelial cell signaling pathways:
a) We utilize rodent models to study retinal vascular disease phenotypes and molecular targets. This is further supported by a variety of cell culture models to investigate candidate cells, including retinal endothelial cells, perivascular cells, immune cells, and the extracellular matrix. These models also explore the complex interactions within this niche, focusing on the connections between immunomodulatory pathways, redox perturbations, and other stressors.
b) Our translational approach involves analyzing clinical data and assessing biological tissues and hemodynamic variables to identify the most informative inflammatory and physiological parameters. This helps in early detection and understanding risk factors associated with retinal vascular disease.
c) We also participate in a range of clinical trials focused on evaluating critical therapeutic approaches for infants, aimed at preventing and treating ROP and other vascular diseases.
24 months research laboratory experience
Working Conditions:
Why You Belong at the University of Oklahoma: The University of Oklahoma fosters an inclusive culture of respect and civility, belonging, and access, which are essential to our collective pursuit of excellence and our determination to change lives. The unique talents, perspectives, and experiences of our community enrich the learning, and working environment at OU, inspiring us to harness our innovation, creativity, and collaboration for the advancement of people everywhere.
Equal Employment Opportunity Statement: The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate based on race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to, admissions, employment, financial aid, housing, services in educational programs or activities, and health care services that the University operates or provides.